We are live on ! Find out more
FLNA

Filana Therapeutics

175 hedge funds and large institutions have $439M invested in Filana Therapeutics in 2022 Q3 according to their latest regulatory filings, with 49 funds opening new positions, 44 increasing their positions, 34 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

113% more first-time investments, than exits

New positions opened: 49 | Existing positions closed: 23

60% more call options, than puts

Call options by funds: $276M | Put options by funds: $173M

57% more capital invested

Capital invested by funds: $279M → $439M (+$160M)

29% more repeat investments, than reductions

Existing positions increased: 44 | Existing positions reduced: 34

17% more funds holding

Funds holding: 149175 (+26)

1.34% more ownership

Funds ownership: 24.89%26.23% (+1.3%)

Holders
175
Holders Change
+26
Holders Change %
+17.45%
% of All Funds
3.01%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
49
Increased
44
Reduced
34
Closed
23
Calls
$276M
Puts
$173M
Net Calls
+$103M
Net Calls Change
+$106M
Name Holding Trade Value Shares
Change
Change in
Stake
Mirae Asset Global Investments
51
Mirae Asset Global Investments
South Korea
$689K +$133K +4,930 +43%
Commonwealth Equity Services
52
Commonwealth Equity Services
Massachusetts
$686K +$75.2K +2,784 +20%
SC
53
Saturna Capital
Washington
$669K
CCFM
54
Clear Creek Financial Management
Washington
$664K -$300K -11,100 -41%
State Board of Administration of Florida Retirement System
55
State Board of Administration of Florida Retirement System
Florida
$664K
Manulife (Manufacturers Life Insurance)
56
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$625K -$17.2K -637 -4%
VOYA Investment Management
57
VOYA Investment Management
Georgia
$621K +$10.3K +381 +3%
IWA
58
IVC Wealth Advisors
Pennsylvania
$620K +$10.8K +400 +3%
Citigroup
59
Citigroup
New York
$619K -$121K -4,487 -23%
Cambridge Investment Research Advisors
60
Cambridge Investment Research Advisors
Iowa
$611K +$21.8K +806 +6%
Janney Montgomery Scott
61
Janney Montgomery Scott
Pennsylvania
$556K +$359K +13,303 New
Creative Planning
62
Creative Planning
Kansas
$549K +$19.4K +718 +6%
VF
63
Virtu Financial
New York
$548K +$354K +13,108 New
Baird Financial Group
64
Baird Financial Group
Wisconsin
$529K -$27.7K -1,026 -8%
SSA
65
Schonfeld Strategic Advisors
New York
$502K +$324K +12,000 New
ASRS
66
Arizona State Retirement System
Arizona
$433K +$1.22K +45 +0.4%
Ensign Peak Advisors
67
Ensign Peak Advisors
Utah
$428K -$27.5K -1,020 -9%
Principal Financial Group
68
Principal Financial Group
Iowa
$426K -$6.18K -229 -2%
Handelsbanken Fonder
69
Handelsbanken Fonder
Sweden
$418K
CWM
70
CCG Wealth Management
California
$413K +$266K +9,866 New
Millennium Management
71
Millennium Management
New York
$379K +$244K +9,051 New
RJFSA
72
Raymond James Financial Services Advisors
Florida
$346K -$27.3K -1,011 -11%
SO
73
STRS Ohio
Ohio
$338K +$16.2K +600 +8%
JIP
74
Jaffetilchin Investment Partners
Florida
$322K +$208K +7,703 New
Janus Henderson Group
75
Janus Henderson Group
United Kingdom
$315K +$27 +1 +0%

FLNA Hedge Fund Activity: Q3 2022 in Review

175 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Filana Therapeutics (FLNA) for Q3 2022, worth a combined $439M — up 57% from $279M a quarter earlier.

Buyers outnumbered sellers: 49 funds opened new FLNA positions and 23 closed out — a net gain of 26 holders — while 44 added to existing stakes and 34 trimmed.

The largest buyer was Invesco, adding an estimated $6.49M. The largest seller was BlackRock, cutting an estimated $4.75M.

  • 175 institutional investors held Filana Therapeutics (FLNA) as of Q3 2022, up from 149 in Q2 2022.
  • Funds reported $439M of Filana Therapeutics stock for Q3 2022, up 57% quarter-over-quarter.
  • 49 funds opened new Filana Therapeutics positions in Q3 2022 and 23 closed out, a net change of +26 holders.
  • The largest Filana Therapeutics buyer in Q3 2022 was Invesco, an estimated $6.49M added.
  • The largest Filana Therapeutics seller in Q3 2022 was BlackRock, an estimated $4.75M sold.

Based on aggregated 13F filings for Q3 2022.